BioSpace News Archive

Rare Pediatric Disease Designation for MYO-101 Program Reflects Compelling Data and Enables Priority Review Voucher Eligibility

Plexus Technology Group, LLC (Plexus TG), a fully KLAS-rated, market-leading, best-of-breed provider of anesthesia information management systems (AIMS), announces a strategic partnership with Synopsis Healthcare, a leading supplier of digital pre-operative assessment for National Health Service (NHS) and private hospitals in the UK

AmideBio LLC, announced today that Dr. Pawel Fludzinski has joined the Company as its new Chief Executive Officer.

Audentes Announces Continuing Positive Data from First Dose Cohort of ASPIRO.

The Wound and Skin Care Division of Coloplast U.S. announced the launch of Biatain Silicone with 3DFit Technology. Biatain Silicone now offers a full-range portfolio of foam dressings designed to give healthcare professionals versatility in the management of exuding wounds or the prevention of pressure injuries.

Pulse Biosciences, Inc. today announced granted non-qualified stock options covering an aggregate of 102,000 shares of Pulse Biosciences common stock to three new employees

Vitrisa Therapeutics, Inc., today announced that it has entered into an option agreement with Ohr Pharmaceutical for certain rights to the data from the MAKO study

UCB today announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab pegol) on the signs and symptoms of active axSpA in patients without x-ray evidence of ankylosing spondylitis (AS).

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride).

NeuroVasc Technologies, Inc., announced today that it has closed a $6.3MM Series B Preferred Stock financing.